Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027? It is currently trading at a 7% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated October 16, 2026 at 3:19 AM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
7% 0.07 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
13% 14% 7%

Related Prediction Markets

Popular Prediction Markets